CXCL5 limits macrophage foam cell formation in atherosclerosis

Journal of Clinical Investigation

Volumn 123, Issue 3, 2013, Pages 1343-1347

  Rousselle, Anthony ^a   Qadri, Fatimunnisa ^a   Leukel, Lisa ^a   Yilmaz, Rüstem ^a   Fontaine, Jean Fred ^a   Sihn, Gabin ^a   Bader, Michael ^a   Ahluwalia, Amrita ^b   Duchene, Johan ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; FOAM CELL; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; LEUKOCYTOSIS; LIPID STORAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MONOCYTE; MONOCYTOSIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHEMOKINE CXCL5; CHOLESTEROL; ENDOTHELIAL CELLS; FOAM CELLS; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, INTERLEUKIN-8B; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84874606362     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66580     Document Type: Article

References (22)

1. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8(10):802-815.
2. Viola A, Luster AD. Chemokines and their receptors: Drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol. 2008;48(1):171-197. (Pubitemid 351756361)
3. Murphy N, et al. Hypercholesterolaemia and circulating levels of CXC chemokines in apoE*3 Leiden mice. Atherosclerosis. 2002;163(1):69-77. (Pubitemid 34615727)
4. Murphy N. Temporal relationships between circulating levels of cc and cxc chemokines and developing atherosclerosis in apolipoprotein E*3 Leiden mice. Arterioscler Thromb Vasc Biol. 2003;23(9):1615-1620. (Pubitemid 37108206)
5. Tabibiazar R. Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol Genomics. 2006;25(2):194-202.
6. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 1998;101(2):353-363. (Pubitemid 28067332)
7. Boisvert WA, et al. Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol. 2006; 168(4):1385-1395.
8. Chavey C, et al. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab. 2009;9(4):339-349.
9. Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36(5):705-716.
10. Duchene J, et al. A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5. J Immunol. 2007;179(7):4849-4856.
11. Mei J, et al. CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity. 2010;33(1):106-117.
12. Mei J, et al. Cxcr2 and Cxcl5 regulate the IL-17/GCSF axis and neutrophil homeostasis in mice. J Clin Invest. 2012;122(3):974-86.
13. Wengner AM, Pitchford SC, Furze RC, Rankin SM. The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood. 2007;111(1):42-49.
14. Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010;120(7):2423-2431.
15. Huo Y. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest. 2001;108(9):1307-1314. (Pubitemid 33107758)
16. Oh J, et al. Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation. J Biol Chem. 2012;287(15):11629-11641.
17. Yakubenko VP, Bhattacharjee A, Pluskota E, Cathcart MK. M 2 Integrin activation prevents alternative activation of human and murine macrophages and impedes foam cell formation. Circ Res. 2011;108(5):544-554.
18. Frisdal E, et al. Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem. 2011;286(35):30926-30936.
19. Gleissner CA, Shaked I, Little KM, Ley K. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol. 2010;184(9):4810-4818.
20. Alexander MR, et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest. 2012;122(1):70-79.
21. Taleb S, et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med. 2009;206(10):2067-2077.
22. Jeyaseelan S. Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am J Respir Cell Mol Biol. 2005; 32(6):531-539. (Pubitemid 40770131)